NCT07535671

Brief Summary

Background and Rationale: Vitamin D deficiency is a major public health concern. While clinical guidelines provide treatment protocols, medication adherence remains a significant barrier to achieving target serum levels. This study aims to evaluate whether a structured patient education program can improve health beliefs and adherence, ultimately leading to better clinical outcomes. Study Procedures: Participants identified with Vitamin D levels \<30 ng/mL will be randomized into two groups. Intervention Group: Patients will receive a face-to-face education session covering the importance of Vitamin D, correct usage, and potential side effects. They will also receive informative brochures and monthly follow-up phone calls to support adherence. Control Group: Patients will receive standard clinical care without additional structured education.Evaluation:Adherence will be monitored using the Medication Possession Ratio (MPR). Serum 25(OH)D levels and Vitamin D Health Belief Scale scores will be reassessed at the 6-month mark to compare the effectiveness of the intervention against the control group.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Nov 2025Jun 2026

Study Start

First participant enrolled

November 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

March 18, 2026

Last Update Submit

April 10, 2026

Conditions

Keywords

Vitamin Dpatient educationrandomized controlled trials

Outcome Measures

Primary Outcomes (2)

  • Change in Serum 25(OH)D Levels

    Assessment of Vitamin D status through serum laboratory analysis

    Baseline and 3 months

  • Change in Medication Possession Ratio (MPR)

    Adherence measured by MPR. Target is defined as \>% 80

    Baseline and 3 months

Study Arms (2)

Control group

NO INTERVENTION

Education group

ACTIVE COMPARATOR
Behavioral: Educational with vitamin D

Interventions

This study implements a pharmacist-led patient education program designed to improve treatment adherence and health beliefs in individuals with vitamin D deficiency (25(OH)D \< 30 ng/mL). The intervention begins with the collection of sociodemographic data and the administration of the Vitamin D Health Belief Scale to establish a baseline. The core intervention involves providing the intervention group (n=30) with structured oral counseling and written educational materials (patient brochures) regarding the clinical importance and proper usage of vitamin D. In contrast, the control group receives standard care. Three months post-intervention, follow-up assessments are conducted via telephone to re-evaluate health beliefs and measure treatment adherence using the Medication Possession Ratio (MPR). The primary success criteria are achieving an MPR ≥ 8

Education group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female,
  • Aged 18 years and older,
  • Hypothyroid disease,
  • Serum vitamin D level \< 30 ng/mL,
  • Providing written informed consent to participate in the study.

You may not qualify if:

  • Male ,
  • Under the age of 18,
  • Patients who do not provide written informed consent,
  • Serum vitamin D levels \> 30 ng/mL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KTU Faculty of Medicine

Trabzon, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Vitamin D

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

March 18, 2026

First Posted

April 17, 2026

Study Start

November 1, 2025

Primary Completion

February 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared to ensure the confidentiality and privacy of the participants, in accordance with the institutional ethics committee's guidelines and local data protection regulations. The data collected during this study contains sensitive clinical information belonging to a specific patient population, and the informed consent obtained from the participants did not include permission for the public sharing or secondary use of their individual raw data by third parties

Locations